Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Talk:Bioblast 2022"

From Bioblast
Line 26: Line 26:
|-
|-
|-
|-
| '''11:30-12:15''' || '''Scientific Session II''' ||  || ||  
| '''11:30-12:15''' || '''Scientific Session II''' ||  || '''Molecular, kinetic, and thermodynamic advances in bioenergetics''' ||  
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 11:30-11:45||  || [[Komlodi Timea]]
|  || || 11:30-11:45||  || [[Komlodi Timea]]
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 11:45-12:00 || ||
|  || || 11:45-12:00 || ||
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:00-12:15 ||[[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]] || [[Chicco Adam J]]
|  || || 12:00-12:15 ||[[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]] || [[Chicco Adam J]]
|-
|-
|-
|-
Line 41: Line 41:
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:15-12:20 || ||
|  || || 12:15-12:20 || ||
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:20-12:25 ||  ||  
|  || || 12:20-12:25 ||  ||  
|-
|-
|-
|-
|  || Molecular, kinetic, and thermodynamic advances in bioenergetics || 12:20-12:30 ||  |
|  || || 12:20-12:30 ||  |
|-
|-
|-
|-
Line 53: Line 53:
|-
|-
|-
|-
| '''14:00-15:00''' ||'''Scientific Session III''' || || ||  
| '''14:00-15:00''' ||'''Scientific Session III''' || || Perspectives of bioenergetics in health and disease ||  
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease || 14:00  - 14:15|| ||
|  || || 14:00  - 14:15|| ||
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease || 14:15  - 14:30 || [[MX Mexiko City Moreno-Sanchez R |Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect]] || [[MX Mexiko City Moreno-Sanchez R]]
|  || || 14:15  - 14:30 || [[MX Mexiko City Moreno-Sanchez R |Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect]] || [[MX Mexiko City Moreno-Sanchez R]]
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease || 14:30  - 14:45 || ||
|  || || 14:30  - 14:45 || ||
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease || 14:45  - 15:00 || ::::## [[Neuzil Jiri|Metabolic switch utilizing ammonia supports proliferation in regenerating liver]] || [[Neuzil Jiri]]
|  || || 14:45  - 15:00 || ::::## [[Neuzil Jiri|Metabolic switch utilizing ammonia supports proliferation in regenerating liver]] || [[Neuzil Jiri]]
|-
|-
|-
|-
Line 92: Line 92:
|-
|-
|-
|-
| '''16:00-17:15''' ||'''Scientific Session IV''' || || ||  
| '''16:00-17:15''' ||'''Scientific Session IV''' || || Perspectives of bioenergetics in health and disease II ||  
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:00  - 16:15|| [[Stiban Johnny|NUBPL: a mitochondrial Complex I deficiency disorder]] || [[Stiban Johnny]]
|  || || 16:00  - 16:15|| [[Stiban Johnny|NUBPL: a mitochondrial Complex I deficiency disorder]] || [[Stiban Johnny]]
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:15  - 16:30 || [[Chakrabarti Sasanka |Rotenone cytotoxicity on SH-SY5Y cells: role of ferroptosis, mitochondria and alpha-synuclein]] || [[Chakrabarti Sasanka]]
|  || || 16:15  - 16:30 || [[Chakrabarti Sasanka |Rotenone cytotoxicity on SH-SY5Y cells: role of ferroptosis, mitochondria and alpha-synuclein]] || [[Chakrabarti Sasanka]]
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:30  - 16:35 || ||
|  || || 16:30  - 16:35 || ||
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:35  - 16:40 || ||
|  || || 16:35  - 16:40 || ||
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:40  - 16:45 || ||
|  || || 16:40  - 16:45 || ||
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease II || 16:45  - 17:00 || ||
|  || || 16:45  - 17:00 || ||
|-
|-
|-
|-
|  || Perspectives of bioenergetics in health and disease || 17:00  - 17:15 ||  [[Karabatsiakis Alexander |Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study]] || [[Karabatsiakis Alexander]]  
|  || || 17:00  - 17:15 ||  [[Karabatsiakis Alexander |Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study]] || [[Karabatsiakis Alexander]]  
|-
|-
|-
|-
Line 123: Line 123:
! Time (CET) !!Type of speech !! Time per lecture  !!Title !! Speaker
! Time (CET) !!Type of speech !! Time per lecture  !!Title !! Speaker
|-
|-
| '''09:15  - 10:35''' || '''Scientific Session V''' ||  || ||  
| '''09:15  - 10:35''' || '''Scientific Session V''' ||  || Mitochondrial pharmacology ||  
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 09:15  - 09:30 || [[Koopman_Werner_JH |The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts]] ||  [[Koopman_Werner_JH]]
|  || || 09:15  - 09:30 || [[Koopman_Werner_JH |The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts]] ||  [[Koopman_Werner_JH]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 09:30  - 09:45 ||  [https://abliva.com/company/ Towards a treatment for mitochondrial disease: Current compounds in clinical development] ||  
|  || || 09:30  - 09:45 ||  [https://abliva.com/company/ Towards a treatment for mitochondrial disease: Current compounds in clinical development] ||  
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 09:45  - 10:00 || || [[Dambrova Maija]]
|  || || 09:45  - 10:00 || || [[Dambrova Maija]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 10:00  - 10:20 || [[MitoKIN |Kinase perturbations redirect mitochondrial function]] || [[Torres-Quesada Omar]]
|  || || 10:00  - 10:20 || [[MitoKIN |Kinase perturbations redirect mitochondrial function]] || [[Torres-Quesada Omar]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology ||  ||  || [[Eduard Stefan]]
|  || ||  ||  || [[Eduard Stefan]]
|-
|-
|-
|-
|  || Mitochondrial pharmacology || 10:20  - 10:35 ||  [[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]]|| [[Chicco Adam J]]
|  || || 10:20  - 10:35 ||  [[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]]|| [[Chicco Adam J]]
|-
|-
|-
|-
Line 150: Line 150:
|-
|-
|-
|-
| '''11:30 - 12:30''' || '''Scientific Session VI''' ||  ||  ||  
| '''11:30 - 12:30''' || '''Scientific Session VI''' ||  ||  Methodological advancements in bioenergetics ||  
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics || 11:30  - 11:45 || [[Ecker Rupert|Contextual Tissue Cytometry with AI – Functional Single Cell Analyses ''in-situ'']] || [[Ecker Rupert]]
|  || || 11:30  - 11:45 || [[Ecker Rupert|Contextual Tissue Cytometry with AI – Functional Single Cell Analyses ''in-situ'']] || [[Ecker Rupert]]
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics || 11:45  - 12:00 || [https://www.incyton.com/            Physiometabolic RTCA on an automated platform for short and long term applications] || [[Wolf Peter]]
|  || || 11:45  - 12:00 || [https://www.incyton.com/            Physiometabolic RTCA on an automated platform for short and long term applications] || [[Wolf Peter]]
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics || 12:00  - 12:15 ||  ||  
|  || || 12:00  - 12:15 ||  ||  
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics || 12:15  - 12:30 ||  ||  
|  || || 12:15  - 12:30 ||  ||  
|-
|-
|-
|-
Line 168: Line 168:
|-
|-
|-
|-
| '''14:00-15:30''' ||'''Scientific Session VII''' || || ||  
| '''14:00-15:30''' ||'''Scientific Session VII''' || || Methodological advancements in bioenergetics II ||  
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics II || 14:00  - 14:15|| [[Cardoso 2022 Abstract Bioblast |Redox monitoring and respiration - a new horizon with the NextGen-O2k]] || [[Cardoso Luiza HD]]  
|  || || 14:00  - 14:15|| [[Cardoso 2022 Abstract Bioblast |Redox monitoring and respiration - a new horizon with the NextGen-O2k]] || [[Cardoso Luiza HD]]  
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics II || 14:15  - 14:30 || [[Garcia-Roves Pablo Miguel |Tuning the assessment of coenzyme Q redox state and respiration in skeletal muscle permeabilized fibers]] || [[Garcia-Roves Pablo Miguel]]
|  || || 14:15  - 14:30 || [[Garcia-Roves Pablo Miguel |Tuning the assessment of coenzyme Q redox state and respiration in skeletal muscle permeabilized fibers]] || [[Garcia-Roves Pablo Miguel]]
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics II || 14:30  - 14:45 || [[Cecatto Cristiane|Mitochondrial calcium uptake capacity is lower than calcium retention capacity in the presence and absence of cyclosporin A]] || [[Cecatto Cristiane]]
|  || || 14:30  - 14:45 || [[Cecatto Cristiane|Mitochondrial calcium uptake capacity is lower than calcium retention capacity in the presence and absence of cyclosporin A]] || [[Cecatto Cristiane]]
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics II || 14:45  - 15:00 || Oxia  || [[Schmitt Sabine]]
|  || || 14:45  - 15:00 || Oxia  || [[Schmitt Sabine]]
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics II || 15:00  - 15:15 ||  ||  
|  || || 15:00  - 15:15 ||  ||  
|-
|-
|-
|-
|  || Methodological advancements in bioenergetics II || 15:15  - 15:30 ||  ||  
|  || || 15:15  - 15:30 ||  ||  
|-
|-
|-
|-

Revision as of 18:27, 17 May 2022

Program

2022-06-29 Day 1 of scientific presentations

Time (CET) Topic Time per lecture Title Speaker
09:15-09:45 1.1 - Opening speech Bioblasts - the taxonomic unit of bioenergetics: mitochondria, chloroplasts, aerobic bacteria Gnaiger Erich
09:45-11:00 Scientific Session I Evolutionary perspectives of bioenergetics
09:45 1.2 - Opening Lecture: The alpha and omega of metabolism: why the Krebs cycle brings the earth to life and our own lives to an end Lane Nick
10:15
10:30 Oxidative stress in photosynthesis Roach Thomas
11:00 Photosynthetic capacity under oscillating light regimes Morosinotto Tomas
11:00-11:30 Coffee Break
11:30-12:15 Scientific Session II Molecular, kinetic, and thermodynamic advances in bioenergetics
11:30-11:45 Komlodi Timea
11:45-12:00
12:00-12:15 Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols Chicco Adam J
12:15 - 12:30 Short talks 4+1
12:15-12:20
12:20-12:25
12:20-12:30
12:30-14:00 Lunch Break
14:00-15:00 Scientific Session III Perspectives of bioenergetics in health and disease
14:00 - 14:15
14:15 - 14:30 Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect MX Mexiko City Moreno-Sanchez R
14:30 - 14:45
14:45 - 15:00 ::::## Metabolic switch utilizing ammonia supports proliferation in regenerating liver Neuzil Jiri
15:00 - 15:30 Short talks 4+1
15:00-15:05
15:05-15:10
15:10-15:15
15:15-15:20
15:20-15:25
15:25-15:30
15:30 - 16:00 Coffee Break
16:00-17:15 Scientific Session IV Perspectives of bioenergetics in health and disease II
16:00 - 16:15 NUBPL: a mitochondrial Complex I deficiency disorder Stiban Johnny
16:15 - 16:30 Rotenone cytotoxicity on SH-SY5Y cells: role of ferroptosis, mitochondria and alpha-synuclein Chakrabarti Sasanka
16:30 - 16:35
16:35 - 16:40
16:40 - 16:45
16:45 - 17:00
17:00 - 17:15 Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study Karabatsiakis Alexander


2022-06-30 Day 2 of scientific presentations

Time (CET) Type of speech Time per lecture Title Speaker
09:15 - 10:35 Scientific Session V Mitochondrial pharmacology
09:15 - 09:30 The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts Koopman_Werner_JH
09:30 - 09:45 Towards a treatment for mitochondrial disease: Current compounds in clinical development
09:45 - 10:00 Dambrova Maija
10:00 - 10:20 Kinase perturbations redirect mitochondrial function Torres-Quesada Omar
Eduard Stefan
10:20 - 10:35 Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols Chicco Adam J
10:35 - 11:00 Poster session
11:00 - 11:30 Coffee Break
11:30 - 12:30 Scientific Session VI Methodological advancements in bioenergetics
11:30 - 11:45 Contextual Tissue Cytometry with AI – Functional Single Cell Analyses in-situ Ecker Rupert
11:45 - 12:00 Physiometabolic RTCA on an automated platform for short and long term applications Wolf Peter
12:00 - 12:15
12:15 - 12:30
12:30 - 14:00 Lunch Break
14:00-15:30 Scientific Session VII Methodological advancements in bioenergetics II
14:00 - 14:15 Redox monitoring and respiration - a new horizon with the NextGen-O2k Cardoso Luiza HD
14:15 - 14:30 Tuning the assessment of coenzyme Q redox state and respiration in skeletal muscle permeabilized fibers Garcia-Roves Pablo Miguel
14:30 - 14:45 Mitochondrial calcium uptake capacity is lower than calcium retention capacity in the presence and absence of cyclosporin A Cecatto Cristiane
14:45 - 15:00 Oxia Schmitt Sabine
15:00 - 15:15
15:15 - 15:30
15:05 - 15:30 Poster session
15:30 - 16:00 Coffee Break
16:00-17:30 Scientific Session VIII
16:00 - 16:15
16:15 - 16:30
16:30 - 16:45
16:45 - 17:00
17:00 - 17:15
17:15 - 17:30